Northwestern Medicine scientists have discovered a new underlying mechanism that controls a specialized group of T-cells, findings that may serve as potential targets for treating inflammatory diseases and cancer, according to a recent study.
Current diagnostic guidelines for a rare type of lymphoma miss a subset of patients with the disease, according to a Northwestern Medicine study published in the journal Blood.
Northwestern Medicine investigators have identified distinct T-cell responses associated with patient outcomes in unvaccinated individuals with severe SARS-CoV-2 pneumonia, according to findings published in Nature Immunology.
Northwestern Medicine scientists have discovered increased immune cell activity in Merkel cell carcinoma tumors, which could help predict treatment response in patients and inform the development of new targeted therapies, according to findings published in the journal Cancer Discovery.
Scientists have discovered a molecular defect that promotes the pathologic immune response in lupus and demonstrated that reversing the defect may potentially reverse the disease.
A study has shown the majority of children and teens with chronic skin diseases feel stigmatized by peers for their condition, are sometimes bullied, and often suffer from depression and anxiety.
Faculty members and fourth-year medical students were recognized for academic and clinical excellence during Feinberg’s Honors Day, held on May 10 in the Hughes auditorium.
More than 450 alumni and guests returned to Feinberg on April 18, 19 and 20 to reconnect with former classmates, learn about the medical school’s latest developments and achievements, and reminisce about their medical school experiences.
Fourth-year Feinberg students excitedly tore open envelopes to reveal their residency matches at this year’s Match Day celebration on March 15.
In findings published in Nature, scientists may have found a way around the limitations of engineered T-cells by borrowing a few tricks from cancer itself.